NAGE R&D to Revenue
Niagen Bioscience Inc · R&D to Revenue
NAGE R&D to Revenue
Latest reported5.08%period ending
NAGE Quarterly R&D/Revenue (0.00% → 5.08%)
Latest values, visible window
High-resolution chart · PNG
NAGE r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 5.0797% | |
| 4.7055% | |
| 5.0533% | |
| 5.2816% | |
| 5.0358% | |
| 4.1272% | |
| 4.515% | |
| 5.043% | |
| 5.7874% | |
| 9.457% | |
| 5.468% | |
| 6.3657% | |
| 6.7165% | |
| 5.2891% | |
| 6.0916% | |
| 7.1734% | |
| 7.4408% | |
| 6.246% | |
| 5.8843% | |
| 5.7546% | |
| 5.6726% | |
| 5.3599% | |
| 6.4163% | |
| 5.9309% | |
| 5.8546% | |
| 6.4064% | |
| 8.702% | |
| 8.6617% | |
| 9.6298% | |
| 11.6242% | |
| 14.062% | |
| 16.6256% | |
| 18.1212% | |
| 21.9126% | |
| 19.2896% | |
| 17.094% | |
| 20.1517% | |
| 19.715% | |
| 9.4676% | |
| 19.6277% | |
| 8.5137% | |
| 6.3295% | |
| 0% | |
| 3.0011% | |
| 2.8749% | |
| 2.3018% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |